Quick Answer
Enveric Biosciences, Inc. reported Total Assets of $5.10 million for the year ending 2025.
- Enveric Biosciences, Inc. showed an increase of +65.3% in Total Assets from 2024 to 2025.
- This data is from Enveric Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2010 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $8.1 thousand | Q3 2011: $24.4 thousand | Q1 2012: $10.3 thousand | Q2 2012: $6.4 thousand | Q3 2012: $6.4 thousand | Q1 2013: $5.4 thousand | Q2 2013: $6.6 thousand | Q3 2013: $4.9 thousand | Q2 2014: $12.0 thousand | Q3 2014: $9.1 thousand | Q4 2014: $5.1 thousand | Q1 2015: $4.46 million | Q3 2015: $21.21 million | Q4 2015: $13.83 million | Q1 2016: $12.63 million | Q2 2016: $15.14 million | Q3 2016: $38.12 million | Q1 2017: $49.68 million | Q2 2017: $47.29 million | Q3 2017: $47.14 million | Q1 2018: $47.92 million | Q2 2018: $45.54 million | Q3 2018: $45.90 million | Q1 2019: $30.51 million | Q2 2019: $29.48 million | Q3 2019: $26.66 million | Q1 2020: $27.14 million | Q2 2020: $27.51 million | Q3 2020: $27.99 million | Q1 2021: $25.79 million | Q2 2021: $23.69 million | Q3 2021: $69.76 million | Q1 2022: $32.18 million | Q2 2022: $28.57 million | Q3 2022: $30.86 million | Q1 2023: $15.85 million | Q2 2023: $9.80 million | Q3 2023: $6.62 million | Q1 2024: $8.85 million | Q2 2024: $6.05 million | Q3 2024: $4.79 million | Q1 2025: $5.10 million | Q2 2025: $3.55 million | Q3 2025: $4.36 million.
- Over the full 15 years of available data (2010 to 2025), Enveric Biosciences, Inc.'s Total Assets has grown by 452,470.2%.
- Historical annual values: Fiscal year 2025: $5.10 million | Fiscal year 2024: $3.08 million | Fiscal year 2023: $4.30 million | Fiscal year 2022: $19.55 million | Fiscal year 2021: $26.72 million | Fiscal year 2020: $4.10 million | Fiscal year 2019: $108.8 thousand | Fiscal year 2018: $29.64 million | Fiscal year 2017: $52.20 million | Fiscal year 2016: $39.51 million | Fiscal year 2014: $5.1 thousand | Fiscal year 2013: $4.5 thousand | Fiscal year 2012: $5.6 thousand | Fiscal year 2011: $22.5 thousand | Fiscal year 2010: $1.1 thousand.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: